Vivos, Inc. (RDGL)
0.0438
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Vivos Shareholders Equity (Quarterly) : 2.756M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.756M |
| March 31, 2026 | 2.697M |
| December 31, 2025 | 1.661M |
| September 30, 2025 | 2.182M |
| June 30, 2025 | 2.679M |
| March 31, 2025 | 3.186M |
| December 31, 2024 | 2.149M |
| September 30, 2024 | 1.196M |
| June 30, 2024 | 1.603M |
| March 31, 2024 | 1.308M |
| December 31, 2023 | 1.365M |
| September 30, 2023 | 1.459M |
| June 30, 2023 | 1.677M |
| March 31, 2023 | 1.413M |
| December 31, 2022 | 1.661M |
| September 30, 2022 | 1.885M |
| June 30, 2022 | 0.893M |
| March 31, 2022 | 1.222M |
| December 31, 2021 | 1.467M |
| September 30, 2021 | 1.424M |
| June 30, 2021 | 1.626M |
| March 31, 2021 | 1.832M |
| December 31, 2020 | 0.032M |
| September 30, 2020 | -0.8702M |
| June 30, 2020 | -0.7846M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.251M |
| December 31, 2019 | -1.480M |
| September 30, 2019 | -1.193M |
| June 30, 2019 | -1.232M |
| March 31, 2019 | -1.046M |
| December 31, 2018 | -0.9422M |
| September 30, 2018 | -34.70M |
| June 30, 2018 | -10.67M |
| March 31, 2018 | -5.087M |
| December 31, 2017 | -4.262M |
| September 30, 2017 | -3.543M |
| June 30, 2017 | -3.134M |
| March 31, 2017 | -3.202M |
| December 31, 2016 | -3.020M |
| September 30, 2016 | -4.088M |
| June 30, 2016 | -5.208M |
| March 31, 2016 | -13.53M |
| December 31, 2015 | -9.715M |
| September 30, 2015 | -8.773M |
| June 30, 2015 | -15.58M |
| March 31, 2015 | -21.17M |
| December 31, 2014 | -20.16M |
| September 30, 2014 | -9.438M |
| June 30, 2014 | -9.673M |
| March 31, 2014 | -9.335M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 1.613B |
| Neogen Corp. | 2.086B |
| QuidelOrtho Corp. | 1.775B |
| Aspira Women's Health, Inc. | -7.256M |
| Biomerica, Inc. | 2.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.880M |
| Total Liabilities (Quarterly) | 0.124M |
| Debt to Equity Ratio | 0.0375 |
| Current Ratio | 48.82 |
| Net Debt Paydown Yield | -0.07% |